76 results
Page 2 of 4
8-K
EX-99.1
ye7cxd7n
11 May 23
Candel Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:31am
8-K
bluipx9v 25zema
17 Apr 23
Candel Therapeutics Receives FDA Fast Track Designation for CAN‑2409 in Non-Small Cell Lung Cancer
8:30am
8-K
EX-99.1
3bzcy vzbdwaoaaru
17 Apr 23
Candel Therapeutics Receives FDA Fast Track Designation for CAN‑2409 in Non-Small Cell Lung Cancer
8:30am
8-K
EX-99.1
fjdpoo35
30 Mar 23
Candel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Highlights
8:30am
8-K
EX-99.1
6rrzh31if y5dtggw5k
6 Dec 22
Other Events
5:30pm
8-K
EX-99.1
b3xl1848lekvcsf9wm
6 Dec 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
4xu4fdrn 399o7kod
29 Nov 22
Regulation FD Disclosure
8:31am
8-K
EX-99.1
22u0dxfpb v1e
18 Nov 22
Other Events
8:30am
8-K
EX-99.1
s5vbv4nzvq
14 Nov 22
Other Events
9:26am
8-K
EX-99.1
ndkue6e72j
10 Nov 22
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
8:30am
8-K
86qvkbkt75r
14 Oct 22
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
EX-99.1
eme8oy fws
7 Sep 22
Candel Therapeutics Announces Two Executive Leadership Appointments
8:02am
DEF 14A
w1uial4 lg4b
2 Sep 22
Definitive proxy
8:30am
S-3
txuudt
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
5kqe4898cbfjz1vh34
5 Aug 22
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:30am